Lv41
450 积分 2025-01-23 加入
Differential Cell–Specific, Regulatory Roles of Fcγ Receptor IIB through IgG in IgA Nephropathy
20天前
已完结
Share on Targeting the Pathogenesis of IgA Nephropathy — A New Treatment Approach?
20天前
已完结
Metabolic Checkpoints in IgA Nephropathy: From Pathogenesis to Precision Medicine
20天前
已完结
Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA Nephropathy
20天前
已完结
IgA Nephropathy in Adults
20天前
已完结
Research Progress on Membranous Nephropathy-Related Antigens and Immune-Targeted Therapy
23天前
已完结
Spectrum of biopsy-proven kidney diseases in 3514 patients at a single center in Northwest China from 2014 to 2023
23天前
已完结
Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
24天前
已完结
The Association between Low-Grade Proteinuria and Adverse Kidney Outcomes in IgA Nephropathy: A Systematic Review and Meta-Analysis
24天前
已完结
Endothelin Receptor Antagonist Ambrisentan, SGLT2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy A Randomized Crossover Trial
1个月前
已完结
皖公网安备34019202002308
